Skip Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 14, Issue 12

2022 June-2 - 218 articles

Cover Story: Recently, radiogenomics, a combination of “Radiomics” and “Genomics”, has played a significant role in and offered a new understanding of cancer’s biology and its behavior in response to standard therapies. It also provides a more precise prognosis, investigation, and analysis of a patient’s cancer. Over the years, artificial intelligence (AI) has provided significant strength to radiogenomics. It syndicates large-scale quantifiable data from radiological medical images enveloped with personalized genomic phenotypes and fabricates a prediction model through various AI methods to stratify patients’ risk, monitor therapeutic approaches, and assess clinical outcomes. This review offers the computational and oncological prospects, achievements, and limitations of AI in radiogenomics studies on cancer in the era of precision medicine. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (218)

  • Article
  • Open Access
10 Citations
3,106 Views
16 Pages

Can 18F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?

  • Vetri Sudar Jayaprakasam,
  • Peter Gibbs,
  • Natalie Gangai,
  • Raazi Bajwa,
  • Ramon E. Sosa,
  • Randy Yeh,
  • Megan Greally,
  • Geoffrey Y. Ku,
  • Marc J. Gollub and
  • Viktoriya Paroder

20 June 2022

This study aimed to assess the usefulness of radiomics features of 18F-FDG PET/CT in patients with locally advanced esophageal cancers (ESCC) in predicting outcomes such as clinical tumor (cT) and nodal (cN) categories, PET response to induction chem...

  • Article
  • Open Access
20 Citations
3,593 Views
17 Pages

Biodegradable Ultrasmall-in-Nano Architectures Loaded with Cisplatin Prodrug in Combination with Ionizing Radiation Induces DNA Damage and Apoptosis in Pancreatic Ductal Adenocarcinoma

  • Pei Pei Che,
  • Ana Katrina Mapanao,
  • Alessandro Gregori,
  • Maria Laura Ermini,
  • Agata Zamborlin,
  • Mjriam Capula,
  • Danitsja Ngadimin,
  • Ben J. Slotman,
  • Valerio Voliani and
  • Elisa Giovannetti
  • + 1 author

20 June 2022

Considering the dismal survival rate, novel therapeutic strategies are warranted to improve the outcome of pancreatic ductal adenocarcinoma (PDAC). Combining nanotechnology for delivery of chemotherapeutics—preferably radiosensitizing agents&md...

  • Article
  • Open Access
7 Citations
5,465 Views
17 Pages

Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies

  • Isabelle Kaiser,
  • Sonja Mathes,
  • Annette B. Pfahlberg,
  • Wolfgang Uter,
  • Carola Berking,
  • Markus V. Heppt,
  • Theresa Steeb,
  • Katharina Diehl and
  • Olaf Gefeller

20 June 2022

Rising incidences of cutaneous melanoma have fueled the development of statistical models that predict individual melanoma risk. Our aim was to assess the validity of published prediction models for incident cutaneous melanoma using a standardized pr...

  • Article
  • Open Access
4 Citations
2,948 Views
13 Pages

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT

  • Shivaprasad Patil,
  • Annett Linge,
  • Hannah Hiepe,
  • Marianne Grosser,
  • Fabian Lohaus,
  • Volker Gudziol,
  • Max Kemper,
  • Alexander Nowak,
  • Dominik Haim and
  • on behalf of the DKTK-ROG
  • + 21 authors

20 June 2022

(1) Background: Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) who are biologically at high risk for the development of loco–regional recurrences after postoperative radiotherapy (PORT) but at intermediate risk acc...

  • Review
  • Open Access
39 Citations
4,577 Views
19 Pages

Heterogeneity in Melanoma

  • Mei Fong Ng,
  • Jacinta L. Simmons and
  • Glen M. Boyle

20 June 2022

There is growing evidence that tumour heterogeneity has an imperative role in cancer development, evolution and resistance to therapy. Continuing advancements in biomedical research enable tumour heterogeneity to be observed and studied more critical...

  • Article
  • Open Access
16 Citations
2,916 Views
10 Pages

Clinical Benefits of Indocyanine Green Fluorescence in Robot-Assisted Partial Nephrectomy

  • Yu-Kuan Yang,
  • Ming-Li Hsieh,
  • Sy-Yuan Chen,
  • Chung-Yi Liu,
  • Po-Hung Lin,
  • Hung-Cheng Kan,
  • See-Tong Pang and
  • Kai-Jie Yu

20 June 2022

Background: To compare the intraoperative and postoperative outcomes of indocyanine green (ICG) administration in robot-assisted partial nephrectomy (RAPN) and report the differences in the results between patients with benign and malignant renal tum...

  • Article
  • Open Access
12 Citations
2,368 Views
12 Pages

Prompt Resumption of Screening Programme Reduced the Impact of COVID-19 on New Breast Cancer Diagnoses in Northern Italy

  • Lucia Mangone,
  • Pamela Mancuso,
  • Maria Barbara Braghiroli,
  • Isabella Bisceglia,
  • Cinzia Campari,
  • Stefania Caroli,
  • Massimiliano Marino,
  • Adele Caldarella,
  • Paolo Giorgi Rossi and
  • Carmine Pinto

20 June 2022

The aim of this study is to evaluate the real impact of COVID-19 during the entire 2020 period, compared with 2019. The data comes from a Cancer Registry in Northern Italy and we compared clinical and treatment characteristics of breast cancer by age...

  • Review
  • Open Access
17 Citations
4,430 Views
15 Pages

Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?

  • Jen-Hao Yeh,
  • Yung-Sung Yeh,
  • Hsiang-Lin Tsai,
  • Ching-Wen Huang,
  • Tsung-Kun Chang,
  • Wei-Chih Su and
  • Jaw-Yuan Wang

20 June 2022

Locally advanced gastric cancer (LAGC) has a poor prognosis with surgical resection alone, and neoadjuvant treatment has been recommended to improve surgical and oncological outcomes. Although neoadjuvant chemotherapy has been established to be effec...

  • Review
  • Open Access
21 Citations
6,084 Views
23 Pages

The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention

  • Peter Gumberger,
  • Bergthor Bjornsson,
  • Per Sandström,
  • Linda Bojmar and
  • Constantinos P. Zambirinis

20 June 2022

Cancer-related mortality is primarily a consequence of metastatic dissemination and associated complications. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and tends to metastasize early, especially in the liver. Emer...

  • Review
  • Open Access
15 Citations
4,931 Views
18 Pages

Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer

  • Mischa de Ridder,
  • Cornelis P. J. Raaijmakers,
  • Frank A. Pameijer,
  • Remco de Bree,
  • Floris C. J. Reinders,
  • Patricia A. H. Doornaert,
  • Chris H. J. Terhaard and
  • Marielle E. P. Philippens

20 June 2022

In recent years, MRI-guided radiotherapy (MRgRT) has taken an increasingly important position in image-guided radiotherapy (IGRT). Magnetic resonance imaging (MRI) offers superior soft tissue contrast in anatomical imaging compared to computed tomogr...

  • Systematic Review
  • Open Access
13 Citations
3,699 Views
13 Pages

20 June 2022

Diffuse low-grade gliomas (LGG) commonly affect young adults and display a slow evolution, with a life expectancy that can surpass 15 years, thanks to multimodal therapeutic management. Therefore, preservation of quality of life (QoL), including sexu...

  • Systematic Review
  • Open Access
30 Citations
3,516 Views
15 Pages

20 June 2022

The aim of the current study was to evaluate the influence of severe radiation-induced lymphopenia (RIL) on the outcomes of esophageal cancer (EC). A systematic review and meta-analysis was performed through the PRISMA guideline. Seventeen studies we...

  • Article
  • Open Access
3 Citations
3,177 Views
11 Pages

Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan

  • Toshiyuki Takemori,
  • Teruya Kawamoto,
  • Hitomi Hara,
  • Naomasa Fukase,
  • Shuichi Fujiwara,
  • Ikuo Fujita,
  • Takuya Fujimoto,
  • Masayuki Morishita,
  • Kazumichi Kitayama and
  • Toshihiro Akisue
  • + 24 authors

20 June 2022

This study aimed to retrospectively analyze the clinical outcomes of patients with pelvic and retroperitoneal bone and soft tissue sarcoma (BSTS). Overall, 187 patients with BSTS in the pelvis and retroperitoneal region treated at 19 specialized sarc...

  • Feature Paper
  • Article
  • Open Access
10 Citations
3,490 Views
15 Pages

20 June 2022

GI microbiota has been implicated in producing the inflammatory tumor microenvironment of several cancers. Women with ovarian cancer often report GI-related symptoms at diagnosis although minimal is known about the possible GI bacteria that may trigg...

  • Review
  • Open Access
36 Citations
5,878 Views
21 Pages

19 June 2022

BPA, a chemical used in the preparation of polycarbonate plastics, is an endocrine disruptor. Exposure to BPA has been suggested to be a risk factor for breast cancer because of its potential to induce estrogen receptor signaling in breast cancer cel...

  • Article
  • Open Access
3 Citations
2,487 Views
10 Pages

Analysis of the Effect of Tumor-Grade Change on the Prognosis of Retroperitoneal Sarcoma

  • Sung Jun Jo,
  • Kyeong Deok Kim,
  • So Hee Lim,
  • Jinseob Kim,
  • Min Jung Kim,
  • Jae Berm Park and
  • Kyo Won Lee

19 June 2022

In retroperitoneal sarcoma (RPS), the change in the tumor grade from the primary tumor to the first local recurrence, and the effect of this change on prognosis, are unknown. The aim of this study is to analyze whether these changes affect the progno...

  • Review
  • Open Access
11 Citations
5,619 Views
26 Pages

Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives

  • Dominic Kaddu-Mulindwa,
  • Lorenz Thurner,
  • Konstantinos Christofyllakis,
  • Moritz Bewarder and
  • Igor Age Kos

19 June 2022

Extranodal marginal zone lymphoma (EMZL) encompasses a subgroup of non-Hodgkin lymphomas that often present with localized involvement and may manifest in a diversity of organs and tissues. EMZL pathogenesis is in some cases linked to chronic inflamm...

  • Review
  • Open Access
21 Citations
4,040 Views
13 Pages

19 June 2022

Metastases to the thyroid gland arise from other malignant tumors such as renal cell carcinoma, colorectal cancer, lung cancer, and breast cancer. In clinical practice, the incidence is low, and the symptoms are not specific, so it is often missed an...

  • Article
  • Open Access
16 Citations
4,441 Views
12 Pages

The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report

  • Claudio Pusceddu,
  • Luigi Mascia,
  • Chiara Ninniri,
  • Nicola Ballicu,
  • Stefano Zedda,
  • Luca Melis,
  • Giulia Deiana,
  • Alberto Porcu and
  • Alessandro Fancellu

19 June 2022

Purpose: Cryoablation (CrA) is a minimally invasive treatment that can be used in primary and metastatic liver cancer. The purpose of this study was to assess the effectiveness of CrA in patients with hepatocellular carcinoma (HCC) and liver metastas...

  • Article
  • Open Access
8 Citations
3,999 Views
18 Pages

A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources

  • Haitao Xiang,
  • Le Zhang,
  • Fanyu Bu,
  • Xiangyu Guan,
  • Lei Chen,
  • Haibo Zhang,
  • Yuntong Zhao,
  • Huanyi Chen,
  • Weicong Zhang and
  • Xuan Dong
  • + 7 authors

19 June 2022

Tumor-specific antigens can activate T cell-based antitumor immune responses and are ideal targets for cancer immunotherapy. However, their identification is still challenging. Although mass spectrometry can directly identify human leukocyte antigen...

  • Article
  • Open Access
15 Citations
4,247 Views
15 Pages

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

  • Ming Yuan,
  • Charles G. Eberhart,
  • Christine A. Pratilas,
  • Jaishri O. Blakeley,
  • Christine Davis,
  • Marija Stojanova,
  • Karlyne Reilly,
  • Alan K. Meeker,
  • Christopher M. Heaphy and
  • Fausto J. Rodriguez

19 June 2022

Subsets of Neurofibromatosis Type 1 (NF1)-associated solid tumors have been shown to display high frequencies of ATRX mutations and the presence of alternative lengthening of telomeres (ALT). We studied the phenotype of combined NF1 and ATRX deficien...

  • Article
  • Open Access
2 Citations
3,075 Views
16 Pages

Environmental Contaminants Modulate Breast Cancer Development and Outcome in TP53 p.R337H Carriers and Noncarriers

  • Viviane K. Q. Gerber,
  • Mariana M. Paraizo,
  • Humberto C. Ibañez,
  • José C. Casali-da-Rocha,
  • Emilia M. Pinto,
  • Diancarlos P. Andrade,
  • Marilea V. C. Ibañez,
  • Heloisa Komechen,
  • Mirna M. O. Figueiredo and
  • Bonald C. Figueiredo
  • + 17 authors

19 June 2022

Two major concerns associated with cancer development in Paraná state, South Brazil, are environmental pollution and the germline TP53 p.R337H variant found in 0.27–0.30% of the population. We assessed breast cancer (BC) risk in rural (C...

  • Review
  • Open Access
8 Citations
4,315 Views
17 Pages

O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway

  • Eunah Kim,
  • Jeong Gu Kang,
  • Eek-hoon Jho,
  • Won Ho Yang and
  • Jin Won Cho

18 June 2022

The balance between cellular proliferation and apoptosis and the regulation of cell differentiation must be established to maintain tissue homeostasis. These cellular responses involve the kinase cascade-mediated Hippo pathway as a crucial regulator....

  • Article
  • Open Access
14 Citations
4,145 Views
10 Pages

Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol

  • Monica Messina,
  • Alfonso Piciocchi,
  • Tiziana Ottone,
  • Stefania Paolini,
  • Cristina Papayannidis,
  • Federica Lessi,
  • Nicola Stefano Fracchiolla,
  • Fabio Forghieri,
  • Anna Candoni and
  • Maria Teresa Voso
  • + 24 authors

18 June 2022

IDH1/2 mutations are common in acute myeloid leukemia (AML) and represent a therapeutic target. The GIMEMA AML1516 observational protocol was designed to study the prevalence of IDH1/2 mutations and associations with clinico-biological parameters in...

  • Article
  • Open Access
5 Citations
3,217 Views
14 Pages

The High Proportion of Discordant EGFR Mutations among Multiple Lung Tumors

  • Hyunwoo Lee,
  • Jin Hee Park,
  • Joungho Han,
  • Young Mog Shim,
  • Jhingook Kim,
  • Yong Soo Choi,
  • Hong Kwan Kim,
  • Jong Ho Cho,
  • Yoon-La Choi and
  • Wan-Seop Kim

18 June 2022

The prevalence of multiple lung cancers has been increasing recently. Molecular analysis of epidermal growth factor receptor (EGFR) mutations in individual tumors of multiple lung cancers is essential for devising an optimal therapeutic strategy. The...

  • Article
  • Open Access
4 Citations
3,519 Views
16 Pages

Methods of Esthetic Assessment after Adjuvant Whole-Breast Radiotherapy in Breast Cancer Patients: Evaluation of the BCCT.core Software and Patients’ and Physicians’ Assessment from the Randomized IMRT-MC2 Trial

  • Tobias Forster,
  • Clara Köhler,
  • Melissa Dorn,
  • Matthias Felix Häfner,
  • Nathalie Arians,
  • Laila König,
  • Semi Ben Harrabi,
  • Ingmar Schlampp,
  • Eva Meixner and
  • Juliane Hörner-Rieber
  • + 8 authors

18 June 2022

The present analysis compares the esthetics assessment by the BCCT.core software in relation to patients’ and physicians’ ratings, based on the IMRT-MC2 trial. Within this trial, breast cancer patients received breast-conserving surgery (...

  • Review
  • Open Access
36 Citations
6,889 Views
14 Pages

Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer

  • Danushka Seneviratne,
  • Pooja Advani,
  • Daniel M. Trifiletti,
  • Saranya Chumsri,
  • Chris J. Beltran,
  • Aaron F. Bush and
  • Laura A. Vallow

18 June 2022

BNCT is a high LET radiation therapy modality that allows for biologically targeted radiation delivery to tumors while reducing normal tissue impacts. Although the clinical use of BNCT has largely been limited to phase I/II trials and has primarily f...

  • Article
  • Open Access
13 Citations
4,580 Views
15 Pages

Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment

  • LaDeidra Monét Roberts,
  • Matthew J. Perez,
  • Kristen N. Balogh,
  • Garnett Mingledorff,
  • Janet V. Cross and
  • Jennifer M. Munson

18 June 2022

At the site of the tumor, myeloid derived suppressor cells (MDSCs) infiltrate and interact with elements of the tumor microenvironment in complex ways. Within the invading tumor, MDSCs are exposed to interstitial fluid flow (IFF) that exists within t...

  • Review
  • Open Access
9 Citations
4,956 Views
14 Pages

18 June 2022

The field of cancer research is famous for its incremental steps in improving therapy. The consistent but slow rate of improvement is greatly due to its meticulous use of consistent cancer biology models. However, as we enter an era of increasingly p...

  • Article
  • Open Access
20 Citations
4,592 Views
14 Pages

Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma

  • Stephanie N. Shishido,
  • Alireza Ghoreifi,
  • Salmaan Sayeed,
  • George Courcoubetis,
  • Amy Huang,
  • Brandon Ye,
  • Sankalp Mrutyunjaya,
  • Inderbir S. Gill,
  • Peter Kuhn and
  • Hooman Djaladat
  • + 1 author

18 June 2022

Urothelial carcinomas (UCs) are a broad and heterogeneous group of malignancies, with the prevalence of upper tract urothelial carcinoma (UTUC) being rare, accounting for only 5–10% of total malignancies. There is a need for additional toolsets...

  • Review
  • Open Access
42 Citations
10,965 Views
22 Pages

Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy

  • Derek Lee,
  • Carl J. Rosenthal,
  • Natalie E. Penn,
  • Zachary Spencer Dunn,
  • Yang Zhou and
  • Lili Yang

18 June 2022

Gamma delta (γδ) T cells are a minor population of T cells that share adaptive and innate immune properties. In contrast to MHC-restricted alpha beta (αβ) T cells, γδ T cells are activated in an MHC-independent mann...

  • Article
  • Open Access
24 Citations
4,057 Views
15 Pages

Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery

  • Valerio Nardone,
  • Alfonso Reginelli,
  • Roberta Grassi,
  • Giovanna Vacca,
  • Giuliana Giacobbe,
  • Antonio Angrisani,
  • Alfredo Clemente,
  • Ginevra Danti,
  • Pierpaolo Correale and
  • Salvatore Cappabianca
  • + 6 authors

18 June 2022

We performed a pilot study to evaluate the use of MRI delta texture analysis (D-TA) as a methodological item able to predict the frequency of complete pathological responses and, consequently, the outcome of patients with locally advanced rectal canc...

  • Article
  • Open Access
7 Citations
3,276 Views
14 Pages

Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status

  • Azzurra Irelli,
  • Alessandro Parisi,
  • Carla D’Orazio,
  • Tina Sidoni,
  • Silvia Rotondaro,
  • Leonardo Patruno,
  • Francesco Pavese,
  • Alberto Bafile,
  • Valter Resta and
  • Katia Cannita
  • + 12 authors

18 June 2022

HER2 is considered one of the most traditional prognostic and predictive biomarkers in breast cancer. Literature data confirmed that the addition of pertuzumab to a standard neoadjuvant chemotherapy backbone (either with or without anthracyclines), i...

  • Review
  • Open Access
4 Citations
3,829 Views
10 Pages

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies

  • Natalia Krawczyk,
  • Tanja Fehm,
  • Eugen Ruckhaeberle,
  • Laura Brus,
  • Valeria Kopperschmidt,
  • Achim Rody,
  • Lars Hanker and
  • Maggie Banys-Paluchowski

18 June 2022

Patients with high-risk non-metastatic breast cancer are recommended for chemotherapy, preferably in the neoadjuvant setting. Beyond advantages such as a better operability and an improved assessment of individual prognosis, the preoperative administ...

  • Article
  • Open Access
29 Citations
4,639 Views
14 Pages

18 June 2022

This study aimed to select a combination of curcumin and luteolin, two phytochemicals from food, at lower concentrations with a higher inhibitory effect on colon cancer growth and investigate possible molecular mechanisms of this anti-colon cancer ef...

  • Review
  • Open Access
18 Citations
7,998 Views
49 Pages

PET-CT in Clinical Adult Oncology—IV. Gynecologic and Genitourinary Malignancies

  • Ahmed Ebada Salem,
  • Gabriel C. Fine,
  • Matthew F. Covington,
  • Bhasker R. Koppula,
  • Richard H. Wiggins,
  • John M. Hoffman and
  • Kathryn A. Morton

18 June 2022

Concurrently acquired positron emission tomography and computed tomography (PET-CT) is an advanced imaging modality with diverse oncologic applications, including staging, therapeutic assessment, restaging and longitudinal surveillance. This series o...

  • Article
  • Open Access
4 Citations
3,556 Views
14 Pages

18 June 2022

Objectives: To describe the self-reported health problems and quality of life among adult-aged Colombian childhood and adolescent cancer survivors. Methods: This is a descriptive cross-sectional study with Colombian childhood cancer survivors (CCS) w...

  • Systematic Review
  • Open Access
28 Citations
7,268 Views
15 Pages

Response to Systemic Therapies in Ovarian Adult Granulosa Cell Tumors: A Literature Review

  • Geertruid J. Brink,
  • Jolijn W. Groeneweg,
  • Lotty Hooft,
  • Ronald P. Zweemer and
  • Petronella O. Witteveen

17 June 2022

For adult granulosa cell tumors (aGCTs), the preferred treatment modality is surgery. Chemotherapy and anti-hormonal therapy are also frequently used in patients with recurrent aGCT. We aimed to review the existing literature on the response to chemo...

  • Review
  • Open Access
17 Citations
5,333 Views
21 Pages

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers

  • Hiroshi Fukushima,
  • Baris Turkbey,
  • Peter A. Pinto,
  • Aki Furusawa,
  • Peter L. Choyke and
  • Hisataka Kobayashi

17 June 2022

Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-targeted therapy that selectively kills cancer cells by systemically injecting an antibody-photoabsorber conjugate (APC) that binds to cancer cells, followed by the application of NIR...

  • Review
  • Open Access
12 Citations
6,402 Views
27 Pages

Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond

  • Federico Pozzo,
  • Tamara Bittolo,
  • Erika Tissino,
  • Antonella Zucchetto,
  • Riccardo Bomben,
  • Laura Polcik,
  • Svenja Dannewitz Prosseda,
  • Tanja Nicole Hartmann and
  • Valter Gattei

17 June 2022

The Notch signaling pathway plays a fundamental role for the terminal differentiation of multiple cell types, including B and T lymphocytes. The Notch receptors are transmembrane proteins that, upon ligand engagement, undergo multiple processing step...

  • Article
  • Open Access
10 Citations
3,066 Views
14 Pages

Contribution of the Skin–Gut Axis to Immune-Related Adverse Events with Multi-System Involvement

  • Alyce M. Kuo,
  • Lukas Kraehenbuehl,
  • Stephanie King,
  • Donald Y. M. Leung,
  • Elena Goleva,
  • Andrea P. Moy,
  • Mario E. Lacouture,
  • Neil J. Shah and
  • David M. Faleck

17 June 2022

Immune-related adverse events (irAEs) frequently complicate treatment with immune checkpoint blockade (ICB) targeting CTLA-4, PD-1, and PD-L1, which are commonly used to treat solid and hematologic malignancies. The skin and gastrointestinal (GI) tra...

  • Article
  • Open Access
22 Citations
3,784 Views
15 Pages

Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy

  • Felix Peisen,
  • Annika Hänsch,
  • Alessa Hering,
  • Andreas S. Brendlin,
  • Saif Afat,
  • Konstantin Nikolaou,
  • Sergios Gatidis,
  • Thomas Eigentler,
  • Teresa Amaral and
  • Ahmed E. Othman
  • + 1 author

17 June 2022

Background: This study investigated whether a machine-learning-based combination of radiomics and clinical parameters was superior to the use of clinical parameters alone in predicting therapy response after three months, and overall survival after s...

  • Article
  • Open Access
4 Citations
2,253 Views
14 Pages

17 June 2022

Assessing cancer prognosis is a challenging task, given the heterogeneity of the disease. Multiple features (clinical, environmental, genetic) have been used for such assessments. The tumor immune microenvironment (TIME) is a key feature, and describ...

  • Review
  • Open Access
24 Citations
5,274 Views
14 Pages

Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?

  • Kordelia Barbullushi,
  • Nicolò Rampi,
  • Fabio Serpenti,
  • Mariarita Sciumè,
  • Sonia Fabris,
  • Pasquale De Roberto and
  • Nicola Stefano Fracchiolla

17 June 2022

Immunotherapy is changing the therapeutic landscape of many hematologic diseases, with immune checkpoint inhibitors, bispecific antibodies, and CAR-T therapies being its greatest expression. Unfortunately, immunotherapy in acute myeloid leukemia (AML...

  • Article
  • Open Access
8 Citations
2,588 Views
12 Pages

Change in Voice Quality after Radiotherapy for Early Glottic Cancer

  • Jana Mekiš,
  • Primož Strojan,
  • Dušan Mekiš and
  • Irena Hočevar Boltežar

17 June 2022

Our aim was to track the changes in voice quality for two years after radiotherapy (RT) for early glottic cancer. A videoendostroboscopy, subjective patient and phoniatrician voice assessments, a Voice Handicap Index questionnaire, and objective acou...

  • Article
  • Open Access
14 Citations
2,674 Views
9 Pages

Close Surgical Margins in Oral and Oropharyngeal Cancer: Do They Impact Prognosis?

  • Dong-Hyun Lee,
  • Geun-Jeon Kim,
  • Hyun-Bum Kim,
  • Hyun-Il Shin,
  • Choung-Soo Kim,
  • Inn-Chul Nam,
  • Jung-Hae Cho,
  • Young-Hoon Joo,
  • Kwang-Jae Cho and
  • Jun-Ook Park
  • + 2 authors

17 June 2022

Introduction. Mucosal margins exhibit a mean shrinkage of 30–40% after resection of oral and oropharyngeal cancers, and an adequate in situ surgical margin frequently results in a pathological close margin. However, the impact on prognosis rema...

  • Article
  • Open Access
16 Citations
2,565 Views
10 Pages

mpMRI-US Fusion-Guided Targeted Cryotherapy in Patients with Primary Localized Prostate Cancer: A Prospective Analysis of Oncological and Functional Outcomes

  • Esaú Fernández-Pascual,
  • Celeste Manfredi,
  • Cristina Martín,
  • Claudio Martínez-Ballesteros,
  • Carlos Balmori,
  • Enrique Lledó-García,
  • Luis Miguel Quintana,
  • Raphael Curvo,
  • Joaquín Carballido-Rodríguez and
  • Juan Ignacio Martínez-Salamanca
  • + 1 author

17 June 2022

Targeted therapy (TT) for prostate cancer (PCa) aims to ablate the malignant lesion with an adequate margin of safety in order to obtain similar oncological outcomes, but with less toxicity than radical treatments. The main aim of this study was to e...

  • Article
  • Open Access
12 Citations
4,390 Views
15 Pages

Prostate-Specific Membrane Antigen (PSMA)-Positive Extracellular Vesicles in Urine—A Potential Liquid Biopsy Strategy for Prostate Cancer Diagnosis?

  • Susann Allelein,
  • Keshia Aerchlimann,
  • Gundula Rösch,
  • Roxana Khajehamiri,
  • Andreas Kölsch,
  • Christian Freese and
  • Dirk Kuhlmeier

17 June 2022

All cells release extracellular vesicles (EVs) to communicate with adjacent and distant cells. Consequently, circulating EVs are found in all bodily fluids, providing information applicable for liquid biopsy in early cancer diagnosis. Studies observe...

  • Article
  • Open Access
10 Citations
4,070 Views
22 Pages

Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions

  • Lucía Celada,
  • Tamara Cubiella,
  • Jaime San-Juan-Guardado,
  • Andrés San José Martínez,
  • Nuria Valdés,
  • Paula Jiménez-Fonseca,
  • Ignacio Díaz,
  • Jose María Enguita,
  • Aurora Astudillo and
  • María-Dolores Chiara
  • + 2 authors

17 June 2022

Hypoxia-inducible factors (HIF) 2α and 1α are the major oxygen-sensing molecules in eukaryotic cells. HIF2α has been pathogenically linked to paraganglioma and pheochromocytoma (PPGL) arising in sympathetic paraganglia or the adrena...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694